EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions

Pankaj Garg, Sulabh Singhal, Prakash Kulkarni, David Horne, Jyoti Malhotra, Ravi Salgia iD, Sharad S Singhal iD

Journal of Clinical Medicine · 18.07.2024 · 13 (14) · 4189

DOI: 10.3390/jcm13144189 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.07.2024. Verfasst von Pankaj Garg und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, GLA University, Mathura 281406, Uttar Pradesh, India. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Defense, The National Cancer Institute of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The leading cause of cancer deaths worldwide is attributed to non-small cell lung cancer (NSCLC), necessitating a continual focus on improving the diagnosis and treatment of this disease. In this review, the latest breakthroughs and emerging trends in managing NSCLC are highlighted. Major advancements in diagnostic methods, including better imaging technologies and the utilization of molecular biomarkers, are discussed. These advancements have greatly enhanced early detection and personalized treatment plans. Significant improvements in patient outcomes have been achieved by new targeted therapies and immunotherapies, providing new hope for individuals with advanced NSCLC. This review discusses the persistent challenges in accessing advanced treatments and their associated costs despite recent progress. Promising research into new therapies, such as CAR-T cell therapy and oncolytic viruses, which could further revolutionize NSCLC treatment, is also highlighted. This review aims to inform and inspire continued efforts to improve outcomes for NSCLC patients globally, by offering a comprehensive overview of the current state of NSCLC treatment and future possibilities.

Schlagwörter

Stichwörter der Autor:innen

CAR-T cell therapygenetic profilinglung cancer diagnosisnon-small cell lung cancer (NSCLC)targeted therapiestherapeutic resistance

Autor:innen und Institutionen

  • Department of Chemistry, GLA University, Mathura 281406, Uttar Pradesh, India.
  • Department of Internal Medicine, Drexel University College of Medicine, Philadelphia, PA 19104, USA.
  • Departments of Medical Oncology & Therapeutics Research, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, USA.
  • Departments of Molecular Medicine, Beckman Research Institute of City of Hope, Comprehensive Cancer Center and National Medical Center, Duarte, CA 91010, USA.

ORCID-Profile: Ravi Salgia, Sharad S Singhal

Förderung

  • United States Department of Defense
  • The National Cancer Institute of the National Institutes of Health

Zitieren

APA

Garg, P., Singhal, S., Kulkarni, P., Horne, D., Malhotra, J., Salgia, R., & Singhal, S. S. (2024). Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions. Journal of Clinical Medicine, 13(14), 4189. https://doi.org/10.3390/jcm13144189

Vancouver

Garg P, Singhal S, Kulkarni P, Horne D, Malhotra J, Salgia R, et al. Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions. Journal of Clinical Medicine. 2024;13(14):4189. doi:10.3390/jcm13144189

BibTeX
@article{Garg2024,
  author = {Garg, Pankaj and Singhal, Sulabh and Kulkarni, Prakash and Horne, David and Malhotra, Jyoti and Salgia, Ravi and Singhal, Sharad S},
  title = {Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {14},
  pages = {4189},
  doi = {10.3390/jcm13144189}
}
Kostenlos starten →